HP
JBIO

HealthInvest Partners’s Jade Biosciences JBIO Stock Holding History

HealthInvest Partners’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
+88,556
New +$1.85M 0.53% 39

Other funds holding JBIO

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HealthInvest Partners's JBIO Position: Q2 2026 in Review

HealthInvest Partners opened a new position in Jade Biosciences (JBIO) in Q2 2026: 88,556 shares worth $1.97M. The stake represents 0.53% of the portfolio and ranks #39 among its holdings.

25 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • HealthInvest Partners held 88,556 shares of Jade Biosciences worth $1.97M as of Q2 2026.
  • Jade Biosciences was a new HealthInvest Partners position in Q2 2026.
  • Jade Biosciences made up 0.53% of HealthInvest Partners's portfolio in Q2 2026, its #39 holding.
  • 25 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.